Site-Specific Olfactory Cleft Opacification Predicts Olfactory Function and Olfactory Training Outcome in Persistent Postinfection Olfactory Dysfunction
Listen to this summary
This study investigates how site-specific opacification within the olfactory cleft (OC) affects olfactory function and the outcomes of olfactory training in patients with persistent postinfectious olfactory dysfunction (PIOD). The authors developed a modified CT scoring system to assess OC opacification, finding that opacification in the upper posterior OC is a significant predictor of baseline olfactory function and training response. The findings suggest that this refined assessment can enhance prognostic accuracy and guide treatment strategies for patients with PIOD.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from International forum of allergy & rhinology
View all →Jun 12, 2026 · International forum of allergy & rhinology
Complications and Clinical Outcomes Following Modified Endoscopic Denker's With Pyriform Aperture Preservation: A Prospective Analysis
Jun 9, 2026 · International forum of allergy & rhinology
Translation and Cross-Cultural Adaptation of the Chronic Rhinosinusitis Control Test for Global Use
Jun 1, 2026 · International forum of allergy & rhinology
Assessing Surgical Extent in Endoscopic Sinus Surgery: A Scoping Review of Scoring Systems
More in Otolaryngology
View all →Sep 23, 2026 · JAMA
Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial
Sep 23, 2026 · The New England journal of medicine
Clinical Uses of Common Genetic Variants Associated with Common Diseases
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome
Sep 22, 2026 · Lancet (London, England)
Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


